MedPath

Ayurvedic Management of Chittodwega (Generalised Anxiety Disorder)

Phase 3
Completed
Conditions
Health Condition 1: null- DSM V Criterion for Generalised Anxiety Disorder.Health Condition 2: F411- Generalized anxiety disorder
Registration Number
CTRI/2018/07/014711
Lead Sponsor
Dr Siddhi Gangadhar Khot
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
56
Inclusion Criteria

1. Individuals between the age group of 20 to 60 years fulfilling the diagnostic criteria of GAD (DSM V)

2. Either sex

Exclusion Criteria

1. Laxana of Unmada (co-morbid psychiatric disorders)

2. Psychotropic drugs four weeks prior to study

3. Patients with substance abuse like alcohol etc.

4. Patients with significant depression (BDI >17)

5. The patients with any other medical complications (Hypertension, Diabetes Mellitus

6. Female patients who are pregnant and lactating

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hamilton Anxiety Rating Scale(HARS)Timepoint: on 0th,15th,30th,45th day of intervention
Secondary Outcome Measures
NameTimeMethod
1.GAD7-Item scale (Spitzer et al 2006) <br/ ><br>2.Beck Depression Inventory (BDI) <br/ ><br>3.Epworth Sleepiness Scale (ESS) <br/ ><br>4.Pittsburg sleep quality <br/ ><br>5.WHO Quality of Life-BREF (WHOQOL-BREF) <br/ ><br>6.Clinical Global Impressions(CGI) <br/ ><br>Timepoint: on 0th,15th,30th,45th day of intervention
© Copyright 2025. All Rights Reserved by MedPath